KR
Kurra Rani Samyukta
About Kurra Rani Samyukta
Data last updated:
Kurra Rani Samyukta has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Walen Pharmaceutical Private Limited and Right Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹33.86 Cr; the largest is Walen Pharmaceutical Private Limited at ₹33.86 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Walen Pharmaceutical Private Limited U24232TG2021PTC156401 | Director | 27 Oct 2021 | 2021 | ₹33.86 Cr (FY 2024) | Active |
| Right Labs Private Limited U24290TG2021PTC156532 | Director | 30 Oct 2021 | 2021 | ₹24,827 (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kurra Rani Samyukta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kurra Rani Samyukta
Kurra Rani Samyukta has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including Walen Pharmaceutical Private Limited and Right Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹33.86 Cr; the largest is Walen Pharmaceutical Private Limited at ₹33.86 Cr (FY 2024).
Kurra Rani Samyukta is associated with 2 companies as Director, including Walen Pharmaceutical Private Limited (₹33.86 Cr), Right Labs Private Limited (₹24,827).
Kurra Rani Samyukta has expertise in General Business.
Kurra Rani Samyukta has 4 years in corporate governance.
By reported revenue, the largest current company of Kurra Rani Samyukta is Walen Pharmaceutical Private Limited, with revenue of ₹33.86 Cr (FY 2024).
The 2 current companies of Kurra Rani Samyukta that report revenue have a combined latest revenue of ₹33.86 Cr.
Kurra Rani Samyukta currently holds positions at 2 companies: Walen Pharmaceutical Private Limited (₹33.86 Cr), Right Labs Private Limited (₹24,827).